SCHEMBL4544097

SCHEMBL4544097

N/C(=C\C(=O)O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4544101 1.00
SCHEMBL4438376 1.00
SCHEMBL10686269 0.80
SCHEMBL8068005 0.80
SCHEMBL28929333 0.80
SCHEMBL10686260 0.80
Propionitrile SCHEMBL28115464 0.79 ALDH1A1 (0.38)
SCHEMBL20338617 0.77 LDHA (0.33)
SCHEMBL468412 0.75
SCHEMBL468414 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113767098-B Solid forms of Toll-like receptor modulators 吉利德科学公司 2025-02-25 CN claimed
EP-1913942-B1 The use of fumaric acid derivatives for inhibition of PGF-induced thymidine uptake of bronchial smooth muscle cells and for inhibition of bronchial smooth cells proliferation BIOGEN IDEC INTERNAT GMBH (CH) 2009-11-11 EP claimed
EP-1663197-B1 THE USE OF FUMARIC ACID DERIVATIVES FOR TREATING CARDIAC INSUFFICIENCY, AND ASTHMA FUMAPHARM AG (CH) 2007-12-05 EP claimed
EP-0560019-B1 Process for the preparation of dialkyl 2,3-pyridinedicarboxylate and derivatives thereof from an alpha, beta-unsaturated oxime and an aminobutenedioate AMERICAN CYANAMID CO (US) 1996-04-24 EP claimed
EP-0560019-A1 Process for the preparation of dialkyl 2,3-pyridinedicarboxylate and derivatives thereof from an alpha, beta-unsaturated oxime and an aminobutenedioate AMERICAN CYANAMID COMPANY (US) 1993-09-15 EP claimed
US-5227491-A Process for the preparation of dialkyl 2,3-pyridinedicarboxylate and derivatives thereof from an α,β-unsaturated oxime and an aminobutenedioate AMERICAN CYANAMID COMPANY (US) 1993-07-13 US claimed
EP-0452094-A2 A method of the preparation of N-hydroxy aspartic acid derivate HOECHST CELANESE CORPORATION (US) 1991-10-16 EP claimed
US-4734368-A FROM AMMONIUM FUMARATE HUELS AKTIENGESELLSCHAFT (DE) 1988-03-29 US claimed
JP-6128205-A None JP disclosed
JP-6056787-A None JP disclosed
US-20250276300-A1 REDUCTION OF MONOMERIC ISOCYANATES BY POROUS MATERIAL BASF SE (DE) 2025-09-04 US disclosed
EP-4291588-B1 REDUCTION OF MONOMERIC ISOCYANATES BY POROUS MATERIAL BASF SE (DE) 2025-08-20 EP disclosed
CN-112384505-B Therapeutic heterocyclic compounds 吉利德科学公司 2025-05-27 CN disclosed
CN-118894801-A Pyrrole sulfonyl derivative, and preparation method and application thereof 天地恒一制药股份有限公司 2024-11-05 CN disclosed
CN-1056492-A The preparation method of pyridine carboxylic acid derivatives HOECHST CELANESE CORP (US) 1991-11-27 CN disclosed
US-5008392-A Reacting 2,3-dihalomaleic acid esters with ammonia or salts, reacting product with alpha, B-unsaturated aldehydes or ketones WACKER-CHEMIE GMBH (DE) 1991-04-16 US disclosed
CN-1049844-A The preparation method of pyridine carboxylic acid derivatives HOECHST CELANESE CORP (US) 1991-03-13 CN disclosed
EP-0125105-B1 IMMOBILIZATION OF CATALYTICALLY ACTIVE MICROORGANISMS IN AGAR GEL FIBERS PFIZER INC. (US) 1989-03-22 EP disclosed
US-4578354-A Immobilization of catalytically active microorganisms in agar gel fibers PFIZER INC. (US) 1986-03-25 US disclosed
EP-0125105-A2 Immobilization of catalytically active microorganisms in agar gel fibers PFIZER INC. (US) 1984-11-14 EP disclosed